Skip to navigation Skip to content

Betaseron

Share

About this Medication
  • Brand Name: Betaseron® (U.S. and Canada) (bay-ta-seer-on)
  • Chemical Name: interferon (in-ter-feer-on) beta-1b
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

Betaseron® and Extavia® are taken by injection

 


Description

Betaseron® and Extavia® are brand names for interferon beta 1b, a medication manufactured by a biotechnological process from one of the naturally occurring interferons (a type of protein).

Betaseron and Extavia are approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsing forms of multiple sclerosis to include clinically isolated syndrome, relapsing remitting disease, and active secondary progressive disease, in adults.

Click here to read the FDA Prescribing Information for Betaseron.

Click here to read the FDA Medication Guide for patients.

Click here to read the FDA Prescribing Information for Extavia.

Click here to read the FDA Medication Guide for Extavia

Support

BETAPLUS® Support Program 
1-844-788-1470
betaseron.com/betaplus-support-program

Financial Assistance Program

BETAPLUS® Financial Support
1-844-788-1470
betaseron.com/betaplus-support-program/financial-support



Share


© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.